(Q44804439)

6 December 2017

Sleep-promoting properties of quetiapine in healthy subjects (English)

1 reference

6 December 2017

Stefan Cohrs

1

1 reference

6 December 2017

Andrea Rodenbeck

2

1 reference

6 December 2017

Zhenghua Guan

3

1 reference

6 December 2017

Kathrin Pohlmann

4

1 reference

6 December 2017

Wolfgang Jordan

5

1 reference

6 December 2017

Andreas Meier

6

1 reference

6 December 2017

Eckart Rüther

7

1 reference

6 December 2017

17 March 2004

1 reference

6 December 2017

1 reference

6 December 2017

174

1 reference

6 December 2017

3

1 reference

6 December 2017

421-429

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-003-1759-5

6 December 2017

0 references

cites work

Effect of neuroleptic treatment on polysomnographic measures in schizophrenia

1 reference

12 December 2020

Antagonizing the effects of experimentally induced sleep disturbance in healthy volunteers by lormetazepam and zolpidem.

1 reference

12 December 2020

Effects of clozapine on sleep: a longitudinal study

1 reference

12 December 2020

Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency.

1 reference

12 December 2020

Epidemiology of prescriptions for neuroleptic drugs: tranquilizers rather than antipsychotics.

1 reference

12 December 2020

Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine

1 reference

12 December 2020

Effects of clozapine on sleep measures and sleep-associated changes in growth hormone and cortisol in patients with schizophrenia

1 reference

12 December 2020

Clinical use of quetiapine in disease states other than schizophrenia.

1 reference

12 December 2020

Restless legs syndrome probably induced by risperidone treatment

1 reference

12 December 2020

Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients

1 reference

12 December 2020

Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants

1 reference

12 December 2020

Delta sleep deficits in schizophrenia: evidence from automated analyses of sleep data

1 reference

12 December 2020

Effects of antipsychotic treatment on polysomnographic measures in schizophrenia: a replication and extension.

1 reference

12 December 2020

The dopamine D1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat

1 reference

12 December 2020

New antipsychotics: the present status

1 reference

12 December 2020

The anatomy of melancholia--focal abnormalities of cerebral blood flow in major depression.

1 reference

12 December 2020

The first night effect: an EEG study of sleep

1 reference

12 December 2020

Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard

1 reference

12 December 2020

Effect of prolonged chlorpromazine administration on the sleep of chronic schizophrenics.

1 reference

12 December 2020

Effects of prolonged administration of pimozide on sleep-EEG patterns in psychiatric patients

1 reference

12 December 2020

Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD.

1 reference

12 December 2020

Effects of methoxamine, and alpha-1 adrenoceptor agonist, and prazosin, an alpha-1 antagonist, on the stages of the sleep-waking cycle in the cat.

1 reference

12 December 2020

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

1 reference

12 December 2020

Stress-induced insomnia: opioid-dopamine interactions

1 reference

12 December 2020

A psychophysiological investigation of the short-term effects of clozapine upon sleep parameters of normal young adults

1 reference

12 December 2020

Electroencephalographic and eye movement patterns during sleep in chronic schizophrenic patients.

1 reference

12 December 2020

Quetiapine attenuates levodopa-induced motor complications in rodent and primate parkinsonian models

1 reference

12 December 2020

Effects of selected phenothiazines on REM sleep in schizophrenics.

1 reference

12 December 2020

Restless legs syndrome and periodic limb movements in sleep

1 reference

12 December 2020

Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo.

1 reference

12 December 2020

Sleep in schizophrenia: a polysomnographic study on drug-naive patients.

1 reference

12 December 2020

Sleep deprivation in the rat: an animal model of mania.

1 reference

12 December 2020

A longitudinal study of EEG sleep in schizophrenia

1 reference

12 December 2020

Effects of methoxamine and alpha-adrenoceptor antagonists, prazosin and yohimbine, on the sleep-wake cycle of the rat.

1 reference

12 December 2020

Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat.

1 reference

12 December 2020

Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds

1 reference

12 December 2020

The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs

1 reference

12 December 2020

Regulation of ionotropic glutamate receptors in the rat brain in response to the atypical antipsychotic seroquel (quetiapine fumarate).

1 reference

12 December 2020

Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy

1 reference

12 December 2020

Effects of promethazine on nocturnal sleep in normal man

1 reference

12 December 2020

Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists.

1 reference

12 December 2020

Seroquel: biochemical profile of a potential atypical antipsychotic.

1 reference

12 December 2020

Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing.

1 reference

12 December 2020

Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents

1 reference

12 December 2020

Abnormal rapid eye movement latencies in schizophrenia

1 reference

12 December 2020

10.1007/S00213-003-1759-5

Identifiers

DOI

1 reference

6 December 2017

1 reference